Bioventus (BVS) director McMurry-Heath gains shares via RSU vesting and new grant
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Bioventus Inc. director Michelle McMurry-Heath reported equity compensation and a vesting event. On June 2, 2026, 32,282 restricted stock units were exercised and converted into the same number of shares of Class A common stock, leaving her with 77,279 shares held directly. Each RSU represents a contingent right to receive one share of Class A common stock, and the RSUs referenced in the footnotes vest based on service on the Board and the timing of the company’s annual stockholder meeting. On June 3, 2026, she also received a grant of 25,146 RSUs as additional equity compensation, which will vest according to the disclosed schedule.
Positive
- None.
Negative
- None.
Insider Trade Summary
32,282 shares exercised/converted
Mixed
3 txns
Insider
McMurry-Heath Michelle
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units | 25,146 | $0.00 | -- |
| Exercise | Restricted Stock Units | 32,282 | $0.00 | -- |
| Exercise | Class A Common Stock | 32,282 | $0.00 | -- |
Holdings After Transaction:
Restricted Stock Units — 25,146 shares (Direct, null);
Class A Common Stock — 77,279 shares (Direct, null)
Footnotes (1)
- Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock. The RSUs vested on June 2, 2026. The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date.
Key Figures
RSUs exercised: 32,282 units
RSU grant: 25,146 units
Shares held after transaction: 77,279 shares
+2 more
5 metrics
RSUs exercised
32,282 units
Exercised into Class A common stock on June 2, 2026
RSU grant
25,146 units
New restricted stock unit award on June 3, 2026
Shares held after transaction
77,279 shares
Class A common stock directly owned following June 2, 2026 exercise
Underlying shares per RSU
1 share per RSU
Each RSU represents a contingent right to one Class A share
Exercise events
1 event, 32,282 units
Derivative exercise/conversion transactions summarized in Form 4
Key Terms
Restricted Stock Units, Class A common stock, vested, Annual Meeting of Stockholders, +1 more
5 terms
Restricted Stock Units financial
"Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Class A common stock financial
"Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock."
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
vested financial
"The RSUs vested on June 2, 2026."
Annual Meeting of Stockholders financial
"the Issuer's first Annual Meeting of Stockholders following the date of grant"
Board of Directors financial
"subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date."
The Board of Directors is a group of people chosen by a company's owners to help make big decisions and oversee how the company is run. They act like a team of advisors or managers, making sure the company stays on track and meets its goals. Their choices can influence the company's success and how it grows.
FAQ
What insider transactions did Bioventus (BVS) disclose for Michelle McMurry-Heath?
Bioventus reported that director Michelle McMurry-Heath acquired equity through RSU-related transactions. On June 2, 2026, 32,282 RSUs were exercised into Class A common stock, and on June 3, 2026 she received a grant of 25,146 additional RSUs as compensation.
What RSU grant did Bioventus (BVS) report for Michelle McMurry-Heath on June 3, 2026?
On June 3, 2026, Michelle McMurry-Heath received a grant of 25,146 restricted stock units. Each RSU represents a contingent right to receive one share of Class A common stock, subject to future vesting based on her continued service on the Board of Directors.
How do the RSUs reported for Bioventus (BVS) director Michelle McMurry-Heath vest?
The RSUs vest on the earlier of the day immediately before the first annual meeting of stockholders after grant or the first anniversary of grant. Vesting requires that Michelle McMurry-Heath continue serving on the Bioventus Board of Directors through the applicable vesting date.
What happened to the previously outstanding Bioventus (BVS) RSUs that vested on June 2, 2026?
RSUs that vested on June 2, 2026 were exercised and converted into 32,282 shares of Class A common stock. After this conversion, the RSU balance for that award dropped to zero, reflecting a full exercise of those vested units into common shares.